prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information inthe Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. consent of the Company and Chardan. As disclosed in Prospectus Supplement No. 2 to the Prospectus, dated July 3, 2025, the offeringperiod was further extended until July 28, 2025, which date could be further extended by the mutual consent of the Company andChardan. The Company is hereby extending the offering period until August 18, 2025, with an option to further extend it by anadditional 15 business days thereafter, subject to the mutual consent of the Company and Chardan, unless terminated earlier by us in Our Ordinary Shares are listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “VVPR.” The last sale price ofour Ordinary Shares on Nasdaq on July 24, 2025 was $5.59 per share.We may further amend or supplement the Prospectus and this prospectus supplement from time to time by filing amendmentsor supplements as required. You should read the entire Prospectus, this prospectus supplement and any amendments or supplements these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation tothe contrary is a criminal offense. The date of this prospectus supplement is July 25, 2025.




